Keystone afternoon breaks are meant for exploring! 40km round trip bike ride with Jennifer Guerriero, PhD to experience the Gap of Dunloe 🌄 was 💯
#KSMyeloidTargets24

We start the day with superb talks from Julie Helft Julie Helft and Jennifer Guerriero Jennifer Guerriero, PhD on TAM heterogeneity and the effect of treatment on macrophage activation in vivo. Also new Macrophage-targeting clinical trial being launched 👏🏻👏🏻👏🏻 #KSMyeloidTargets24

Looking forward to welcoming everyone to beautiful Killarney for #KSMyeloidTargets24 with co-organizer Max, and discussing how academia & industry can align their efforts to develop effective myeloid cell targeted therapies for cancer.

So great to visit friends and colleagues OU Health Stephenson Cancer Center. So proud of Rafeh Naqash, MD and all that he has accomplished! 🌟

So incredibly proud of Dr Adam Nelson in the #guerrierolab Brigham and Women’s Department of Surgery Dana-Farber’s Breast Oncology Center for receiving a 3-year CIHR postdoctoral fellowship to study novel ways of treating #brca associated #breastcancer . So grateful to CIHR for this funding!
👇🏼Victory Bell!!

Super excited to support Robert Ferris, MD, PhD in VP election Society for Immunotherapy of Cancer! Bob is a visionary physician-scientist & executive leader whose career is dedicated to translational #immunology & #immunotherapy . Amazing potential to lead the society. Plz vote for Bob!
contentsharing.net/actions/email_…

Apply to the #SITC SCION 2025 program and develop a cancer #immunotherapy clinical trial protocol with appropriate clinical and biomarker endpoints. Navigate unique considerations that accompany cancer immunotherapy trials. Apply by July 22, 2024: go.sitcancer.org/4cAoQjC

So many congratulations to Saman Maleki, PhD. So well deserved my friend!

Join us in a few weeks in Ireland to talk about targeting myeloid cells for cancer therapy! #ksmyeloidtargets24

Congratulations to Dr Adam Nelson from the Guerriero Lab Brigham and Women’s Department of Surgery on his #AACR24 presentation on the efficacy and TME response to a PARP1 selective inhibitor from Duke Street Bio.

Congratulations to Kenichi Shimada from the Guerriero Lab Brigham and Women’s Department of Surgery and Dana-Farber’s Breast Oncology Center HiTS @ Harvard on his #aacr24 presentation on spatial and gene expression analysis of the mechanisms by which ER+ breast tumors may regulate T cells. 👏🏼👏🏼
Dr. E Mittendorf
Ludwig Cancer

Ludwig Harvard Medical School Co-director george demetri, a scientist and physician famed for his contributions to cancer drug development, shared his unique perspective in opening remarks for a session at #AACR24 titled: 'In the Eye of the Beholder: Equipoise in Cancer Clinical Trials.'

Don't miss Adam Nelson, Ph.D. sharing his research on PARP1 selective inhibitor DSB1559 efficacy in BRCA1-associated #TNBC at today's #AACR24 poster session on DNA damage and repair. @jennguerriero
abstractsonline.com/pp8/#!/20272/p…

Closing out #AACR24 with Cancer Research Night at Petco Park with @padres Judith Varner Greenberg Lab and Ira Mellman
to raise funds to help advance our mission to prevent and cure all cancers.

Targeting the Tumor Microenvironment for the Benefit of Cancer Patients: The AACR Tumor Microenvironment Working Group addressed this topic during its #AACR24 Town Hall, moderated by Steering Committee Chair Mikala Egeblad and Chair-Elect Edna Cukierman. Mikala Egeblad Dr. Edna Cukierman, Ph.D.

Participate in a discussion on “New Frontiers in Cancer Immunotherapy” presented by Irish Immunology and Society for Immunotherapy of Cancer. Join us Sept. 1 in Dublin, Ireland to engage with experts and explore emerging topics. Learn more: ow.ly/XSto50R5QUs
Jennifer Guerriero, PhD JL

The Guerriero and Geoffrey Shapiro MD PhD Labs AACR - with Kenichi Shimada, Adam Nelson and Renyan Liu talking science and moving our collaborations on #breastcancer forward. So much important science to do when we get back to Dana-Farber’s Breast Oncology Center and Brigham and Women’s Department of Surgery.

This will be incredible science and fun!! Join Society for Immunotherapy of Cancer and Irish Immunology in Dublin in Sept to explore emerging concepts in #cancer #immunology .

SO grateful for these colleagues and friends. Science moves forward when we work together to understand complex immunology. Great times chatting science and fun AACR.

Great to see so many friends and colleagues at #AACR24 !

Jennifer Guerriero, PhD Peter WT Pisters, MD Richard Gorlick